07.06.2013 Views

NEW YORK STATE URBAN DEVELOPMENT CORPORATION d/b/a ...

NEW YORK STATE URBAN DEVELOPMENT CORPORATION d/b/a ...

NEW YORK STATE URBAN DEVELOPMENT CORPORATION d/b/a ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Market: Real Estate and Industrial/Economic Development<br />

ESD Involvement: After the acquisition of Wyeth by Pfizer in 2009, the decision was made<br />

to exit the Facility due to redundancy with other existing Pfizer research<br />

facilities and the retraction of Pfizer’s in-house research activities.<br />

From 2009 to 2010, the employee base was reduced until only a basic<br />

maintenance staff was left in place. During the two years since the<br />

closing, Pfizer has maintained the Facility and has also employed two<br />

different internationally known marketing firms to market the Facility.<br />

The current marketing firm is Cushman and Wakefield.<br />

Competition: N/A<br />

Past ESD Support: N/A<br />

B. The Project<br />

Completion: June 2014<br />

Over the last two years, there has been cursory interest in the Facility<br />

and site by potential purchasers. Barriers to purchase include significant<br />

operational costs and the large size of the Facility.<br />

The Facility was originally scheduled for auction on February 4, 2012<br />

(rescheduled for April 2, 2012), but at the request of ESD, Pfizer has<br />

delayed the auction. CCIDA, through CIDA, will acquire the Facility from<br />

Pfizer at a nominal cost so that the pending auction can be forestalled.<br />

This will provide more time and opportunity to present the Facility for<br />

acquisition by a responsible party, which would create investment and<br />

employment opportunities. ESD proposes to make a working capital<br />

grant of $1,200,000 to CIDA for operational costs while the Facility is<br />

being marketed to a new end user.<br />

Activity: CIDA will acquire, maintain and promote the Facility to potential new<br />

end users. The site has been used, continually upgraded and improved as<br />

a premier pharmaceutical research facility, has sophisticated private<br />

water and sewage treatment facilities, and is served by natural gas. CIDA<br />

intends to enter into a management agreement with a third party for the<br />

day-to-day operations of the Facility.<br />

Results: The project is expected to engage an end user that will create<br />

investment and employment opportunities in Chazy.<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!